Germany · Biopharma startup

Invitris

Invitris is a biotech company that develops protein-based drugs.

Funding reportedLast round: Pre-seed

BiopharmaGarching Bei Múnchen, Germany

What company datasets say Invitris raised

Funding, as reported

Reported in all500kin the source's currency
Rounds1
Last roundPre-seed
Last round dateApr 2023
Investors listed2
Y CombinatorW23

On 2 portfolio pages

Investors who name them

Each firm lists Invitris on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biopharma in Germany

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Invitris in front of investors. Or tell us what we have wrong.